+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death



THAP5 is a human cardiac-specific inhibitor of cell cycle that is cleaved by the proapoptotic Omi/HtrA2 protease during cell death



American Journal of Physiology. Heart and Circulatory Physiology 297(2): H643



Omi/HtrA2 is a mitochondrial serine protease that has a dual function: while confined in the mitochondria, it promotes cell survival, but when released into the cytoplasm, it participates in caspase-dependent as well as caspase-independent cell death. To investigate the mechanism of Omi/HtrA2's function, we set out to isolate and characterize novel substrates for this protease. We have identified Thanatos-associated protein 5 (THAP5) as a specific interactor and substrate of Omi/HtrA2 in cells undergoing apoptosis. This protein is an uncharacterized member of the THAP family of proteins. THAP5 has a unique pattern of expression and is found predominantly in the human heart, although a very low expression is also seen in the human brain and muscle. THAP5 protein is localized in the nucleus and, when ectopically expressed, induces cell cycle arrest. During apoptosis, THAP5 protein is degraded, and this process can be blocked using a specific Omi/HtrA2 inhibitor, leading to reduced cell death. In patients with coronary artery disease, THAP5 protein levels substantially decrease in the myocardial infarction area, suggesting a potential role of this protein in human heart disease. This work identifies human THAP5 as a cardiac-specific nuclear protein that controls cell cycle progression. Furthermore, during apoptosis, THAP5 is cleaved and removed by the proapoptotic Omi/HtrA2 protease. Taken together, we provide evidence to support that THAP5 and its regulation by Omi/HtrA2 provide a new link between cell cycle control and apoptosis in cardiomyocytes.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056102731

Download citation: RISBibTeXText

PMID: 19502560

DOI: 10.1152/ajpheart.00234.2009


Related references

HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. Journal of Biological Chemistry 277(1): 445-454, 2002

Evolution of mitochondrial cell death pathway: Proapoptotic role of HtrA2/Omi in Drosophila. Biochemical and Biophysical Research Communications 356(4): 993-997, 2007

Specific protein interaction of human Pag with Omi/HtrA2 and the activation of the protease activity of Omi/HtrA2. Free Radical Biology and Medicine 40(2): 275-284, 2006

Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. Journal of Biological Chemistry 279(48): 50295-50301, 2004

Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. American Journal of Physiology. Renal Physiology 288(2): F371, 2005

A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Molecular Cell 8(3): 613-621, 2001

A proteome-wide CDK/CRK-specific kinase inhibitor promotes tumor cell death in the absence of cell cycle progression. Chemistry and Biology 12(10): 1103-1115, 2005

The serine protease HtrA2 cleaves UCH-L1 and inhibits its hydrolase activity: implication in the UCH-L1-mediated cell death. Biochemical and Biophysical Research Communications 415(1): 24-29, 2011

The serine protease Omi/HtrA2 is involved in XIAP cleavage and in neuronal cell death following focal cerebral ischemia/reperfusion. Neurochemistry International 50(1): 172-180, 2007

Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death. Journal of Biological Chemistry 279(19): 20221-20233, 2004

Characterization of a novel and specific inhibitor for the pro-apoptotic protease Omi/HtrA2. Journal of Biological Chemistry 278(13): 11489-11494, 2003

Interleukin 18 is a proapoptotic and a proinflammatory cytokine and induces human cardiac endothelial cell death via activation of nuclear factor kappaB. Circulation 108(17 Suppl.): IV-23, 2003

Protease inhibitor 10 inhibits tumor necrosis factor a-induced cell death. Evidence for the formation of intracellular high Mr protease inhibitor 10-containing complexes. The Journal of Biological Chemistry 275(34): 385-9, 2000

Protease inhibitor 10 inhibits tumor necrosis factor alpha -induced cell death. Evidence for the formation of intracellular high M(r) protease inhibitor 10-containing complexes. Journal of Biological Chemistry 275(34): 26385, 2000